Literature DB >> 12203214

Growth index is independent of microvessel density in non-small-cell lung carcinomas.

Efthymia Tsoli1, Panayotis Zacharatos, Dimitra Dasiou-Plakida, John Peros, Kostas Evangelou, Athanassios I Zavras, Drakoulis Yannoukakos, Irene Konstantopoulou, Panayiotis J Asimacopoulos, Christos Kittas, Vassilis G Gorgoulis.   

Abstract

Induction of angiogenesis is essential for carcinogenesis and facilitates the processes of tumor development and metastasis. Vascular endothelial growth factor (VEGF) is an important angiogenic regulator under physiologic and pathologic conditions. To elucidate the role of angiogenesis in malignant growth, we evaluated angiogenesis and VEGF expression in a panel of 68 non-small-cell lung carcinomas (NSCLCs) and examined their relation with the kinetic parameters, ploidy, and p53 protein status, which have been analyzed previously. Angiogenesis was estimated as microvascular density (MVD) of the tumor area by CD31 immunodetection. Expression of VEGF was also immunohistochemically evaluated. All possible associations were assessed through a series of statistical methods. The mean MVD value was 39 microvessels/mm(2), and high VEGF immunoreactivity was observed in all specimens, with a mean percentage of positive cells of 73%. The relation between MVD and VEGF expression was not statistically significant (P = 0.065). No association was observed between MVD or VEGF levels with the proliferation index, apoptotic index, tumor ploidy status, p53 expression, and overall survival. We conclude that in a subset of NSCLCs, angiogenesis may be associated with VEGF, but other factors also participate in this process. Angiogenesis and growth (proliferation and apoptosis) are independent and probably differentially operated procedures, with only growth partially controlled by p53 protein expression. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203214     DOI: 10.1053/hupa.2002.125379

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer.

Authors:  Efthimia Tsoli; Petros K Tsantoulis; Alexandros Papalambros; Branko Perunovic; David England; David A Rawlands; Gary M Reynolds; Dimitrios Vlachodimitropoulos; Susan L Morgan; Chara A Spiliopoulou; Thanos Athanasiou; Vassilis G Gorgoulis
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

2.  A three-dimensional analysis of blood vessels in bronchioloalveolar carcinoma.

Authors:  Takeshi Uehara; Takayuki Honda; Kenji Sano; Tsutomu Hachiya; Hiroyoshi Ota
Journal:  Lung       Date:  2004       Impact factor: 2.584

Review 3.  Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients.

Authors:  Denisa Baci; Elona Cekani; Andrea Imperatori; Domenico Ribatti; Lorenzo Mortara
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

4.  The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers.

Authors:  J Nakano; C Huang; D Liu; D Masuya; H Yokomise; M Ueno; R Haba; S Sumitomo
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640

5.  Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer.

Authors:  P Sardari Nia; C Colpaert; B Blyweert; B Kui; P Vermeulen; M Ferguson; J Hendriks; J Weyler; F Pezzella; E Van Marck; P Van Schil
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.